CNR1 and obesity due to melanocortin 4 receptor deficiency: The clinical studies with CB1 agonists, partial agonists, inverse agonists and neutral antagonists clearly point out the CB1R as a potential effective target for the treatment of obesity [2,102,105,106,107].